Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Xilio Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-12-08
Purchase
2021-12-10
8:33 pm
Xilio Therapeutics Inc.XLOBain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Fund II L.P.
Bain Capital Life Sciences Investors II LLC
BCLS II Investco LP
BCLS II Investo (GP) LLC
BCIP Life Sciences Associates LP
10% Owner
42,469$9.6579$410,1612,805,413
(Indirect)
View
2021-10-26
Purchase(A)
2021-11-03
4:20 pm
Xilio Therapeutics Inc.XLOSV7 Impact Medicine Fund LP
SV7 (IMF) GP LLP
10% Owner
625,000$16$10,000,0003,227,264
(Indirect
Direct)
View
2021-10-26
Purchase
2021-10-28
7:15 pm
Xilio Therapeutics Inc.XLOFlynn James E
Deerfield Mgmt L.P.
DEERFIELD PARTNERS L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Mgmt V L.P.
Possible Member of 10% Group
10% Owner
775,000$16$12,400,0001,143,972
(Indirect)
View
2021-10-26
Purchase
2021-10-26
5:30 pm
Xilio Therapeutics Inc.XLORiverVest Venture Fund IV L.P.
10% Owner
250,000$16$4,000,0001,441,444
(Indirect)
View
2021-10-26
Purchase
2021-10-26
5:04 pm
Xilio Therapeutics Inc.XLORock Springs Capital Management LP
Rock Springs Capital LLC
Rock Springs Capital Master Fund LP
Four Pines Master Fund LP
10% Owner
500,000$16$8,000,0001,256,472
(Indirect)
View
2021-10-26
Purchase
2021-10-26
5:02 pm
Xilio Therapeutics Inc.XLOBAY CITY CAPITAL LLC
10% Owner
312,500$16$5,000,0001,129,490
(Indirect)
View
2021-10-26
Purchase
2021-10-26
5:01 pm
Xilio Therapeutics Inc.XLOAtlas Venture Fund XI L.P.
Atlas Venture Opportunity Fund I L.P.
10% Owner
187,500$16$3,000,000735,942
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-01-01
Option Award
2023-01-04
4:14 pm
N/A
2032-12-31
Xilio Therapeutics Inc.XLORusso Rene
CEO
350,000$0350,000
(Direct)
View
2023-01-01
Option Award
2023-01-04
4:11 pm
N/A
2032-12-31
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
PRESIDENT AND HEAD OF R & D
136,500$0136,500
(Direct)
View
2023-01-01
Option Award
2023-01-04
4:09 pm
N/A
2032-12-31
Xilio Therapeutics Inc.XLOEnglish Edward C
PRINCIPAL ACCOUNTING OFFICER
24,000$024,000
(Direct)
View
2022-11-09
Ownership
2022-11-16
4:16 pm
N/A
N/A
Xilio Therapeutics Inc.XLOEnglish Edward C
Principal Accounting Officer
0$079,399
(Direct)
View
2022-09-15
Option Award
2022-09-16
4:15 pm
N/A
2032-09-14
Xilio Therapeutics Inc.XLOHeyman Tomas J.
Director
26,400$026,400
(Direct)
View
2022-06-15(A)
Option Award
2022-06-23
7:30 pm
N/A
2032-06-14
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
PRESIDENT AND HEAD OF R & D
20,000$020,000
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:31 pm
N/A
2032-06-14
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
PRESIDENT AND HEAD OF R & D
20,000$020,000
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:30 pm
N/A
2032-06-14
Xilio Therapeutics Inc.XLORossi Christina
Director
13,200$013,200
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:30 pm
N/A
2032-06-14
Xilio Therapeutics Inc.XLORoss Michael Jay
Director
13,200$013,200
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:30 pm
N/A
2032-06-14
Xilio Therapeutics Inc.XLOClancy Paul J
Director
13,200$013,200
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:30 pm
N/A
2032-06-14
Xilio Therapeutics Inc.XLOXu Yuan
Director
13,200$013,200
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:30 pm
N/A
2032-06-14
Xilio Therapeutics Inc.XLOBonstein Sara
Director
13,200$013,200
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:08 pm
N/A
2032-06-14
Xilio Therapeutics Inc.XLOROSS ROBERT W.
Director
26,400$026,400
(Direct)
View
2022-02-22
Option Award
2022-02-24
5:30 pm
N/A
2032-02-21
Xilio Therapeutics Inc.XLOGiovine Salvatore
CHIEF FINANCIAL OFFICER
49,500$049,500
(Direct)
View
2022-02-22
Option Award
2022-02-24
5:30 pm
N/A
2032-02-21
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
PRESIDENT OF R & D AND CMO
65,000$065,000
(Direct)
View
2022-02-22
Option Award
2022-02-24
5:30 pm
N/A
2032-02-21
Xilio Therapeutics Inc.XLORusso Rene
CEO AND PRESIDENT
150,000$0150,000
(Direct)
View
2022-01-04
Option Award
2022-01-06
6:48 pm
N/A
2032-01-03
Xilio Therapeutics Inc.XLOXu Yuan
Director
26,400$026,400
(Direct)
View
2021-12-22(A)
Option Award
2022-01-04
5:32 pm
N/A
2031-12-21
Xilio Therapeutics Inc.XLORusso Rene
CEO AND PRESIDENT
100,000$0100,000
(Direct)
View
2021-12-22
Option Award
2021-12-23
7:06 pm
N/A
2031-12-21
Xilio Therapeutics Inc.XLORusso Rene
CEO AND PRESIDENT
100,000$0100,000
(Direct)
View
2021-10-26
Ownership
2021-11-05
6:26 pm
N/A
N/A
Xilio Therapeutics Inc.XLOBain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Fund II L.P.
Bain Capital Life Sciences Investors II LLC
BCLS II Investco LP
BCLS II Investo (GP) LLC
BCIP Life Sciences Associates LP
10% Owner
0$02,762,944
(Indirect)
View
2021-10-26(A)
Conversion
2021-11-03
4:20 pm
N/A
N/A
Xilio Therapeutics Inc.XLOSV7 Impact Medicine Fund LP
SV7 (IMF) GP LLP
10% Owner
26,022,654$03,227,264
(Direct)
View
2021-10-26
Conversion
2021-10-28
7:15 pm
N/A
N/A
Xilio Therapeutics Inc.XLOFlynn James E
Deerfield Mgmt L.P.
DEERFIELD PARTNERS L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Mgmt V L.P.
Possible Member of 10% Group
10% Owner
15,129,450$01,143,972
(Indirect)
View
2021-10-26
Conversion
2021-10-28
3:57 pm
N/A
N/A
Xilio Therapeutics Inc.XLOFIL Ltd
See Remark 1
2,296,403$0218,705
(Indirect)
View
2021-10-26
Conversion
2021-10-28
3:45 pm
N/A
N/A
Xilio Therapeutics Inc.XLOFMR LLC
See Remark 1
19,754,248$030,780
(Indirect)
View
2021-10-26
Conversion
2021-10-28
12:55 pm
N/A
N/A
Xilio Therapeutics Inc.XLOSV7 Impact Medicine Fund LP
SV7 (IMF) GP LLP
10% Owner
26,022,654$02,602,264
(Direct)
View
2021-10-26
Conversion
2021-10-26
8:31 pm
N/A
N/A
Xilio Therapeutics Inc.XLOTAKEDA PHARMACEUTICAL CO LTD
Takeda Ventures Inc.
10% Owner
2,950,242$01,475,121
(Indirect)
View
2021-10-26
Conversion
2021-10-26
5:30 pm
N/A
N/A
Xilio Therapeutics Inc.XLORiverVest Venture Fund IV L.P.
10% Owner
1,191,444$01,441,444
(Indirect)
View
2021-10-26
Conversion
2021-10-26
5:06 pm
N/A
N/A
Xilio Therapeutics Inc.XLOMerck KGaA
10% Owner
7,148,664$0680,825
(Indirect)
View
2021-10-26
Conversion
2021-10-26
5:04 pm
N/A
N/A
Xilio Therapeutics Inc.XLORock Springs Capital Management LP
Rock Springs Capital LLC
Rock Springs Capital Master Fund LP
Four Pines Master Fund LP
10% Owner
9,531,553$01,256,472
(Indirect)
View
2021-10-26
Conversion
2021-10-26
5:02 pm
N/A
N/A
Xilio Therapeutics Inc.XLOBAY CITY CAPITAL LLC
10% Owner
8,578,397$01,129,490
(Indirect)
View
2021-10-26
Conversion
2021-10-26
5:01 pm
N/A
N/A
Xilio Therapeutics Inc.XLOAtlas Venture Fund XI L.P.
Atlas Venture Opportunity Fund I L.P.
10% Owner
26,728,062$0735,942
(Indirect)
View
2021-10-26
Option Award
2021-10-26
5:01 pm
N/A
2030-07-22
Xilio Therapeutics Inc.XLOClancy Paul J
Director
109,561$0109,561
(Direct)
View
2021-10-26
Conversion
2021-10-26
4:51 pm
N/A
N/A
Xilio Therapeutics Inc.XLOAlexandria Venture Investments LLC
10% Owner
1,747,449$0166,423
(Direct)
View
2021-10-21
Option Award
2021-10-25
5:18 pm
N/A
2031-10-20
Xilio Therapeutics Inc.XLORusso Rene
CEO and President
10% Owner
50,041$050,041
(Direct)
View
2021-10-21
Option Award
2021-10-25
5:18 pm
N/A
2031-10-20
Xilio Therapeutics Inc.XLORoss Michael Jay
Director
26,400$026,400
(Direct)
View
2021-10-21
Option Award
2021-10-25
5:17 pm
N/A
2031-10-20
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
President of R & D and CMO
157,058$0157,058
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, Next